Stock screener
Filter every US stock on the same numbers behind our pages, from P/E to insider buying. Or start from one of the ready-made ideas.
290 stocks
Prices and filings as of the close on Oct 30, 2026
| # | Company | Share price | 1D | Market cap | Insider net 3M | Buyers 3M | Insiders % | Institutions % | Holders chg. | Superinvestors | Short % shares |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | $504.80 | −10.9% | $824B | −$106M | 0 | 0.43% | 72.8% | +24.6% | 7 | 2.4% | |
| 2 | $406.97 | −0.96% | $365B | −$661K | 0 | 0.18% | 87.7% | +10.7% | 8 | 1.8% | |
| 3 | $250.43 | −4.1% | $256B | −$318M | 0 | 3.3% | 75.4% | +17.5% | – | 2.6% | |
| 4 | $306.08 | −7.3% | $108B | −$348M | 0 | 2.8% | 78.3% | +13.3% | 4 | 5.1% | |
| 5 | $840.70 | −8.6% | $75.4B | −$64.8M | 0 | 1.0% | 91.8% | +20.9% | 1 | 8.3% | |
| 6 | $52.15 | +1.9% | $57.4B | −$144K | 1 | 0.78% | 92.4% | +16.1% | 4 | 2.6% | |
| 7 | $258.70 | −10.9% | $44.9B | −$123M | 0 | 11.4% | 73.6% | +39.5% | 1 | 5.3% | |
| 8 | $274.37 | −7.4% | $42.9B | −$4.1M | 0 | 0.25% | 97.3% | +15.5% | 1 | 5.5% | |
| 9 | $32.12 | +0.38% | $42.2B | −$158M | 0 | 85.0% | 57.1% | +29.3% | 4 | 4.0% | |
| 10 | $191.31 | +0.55% | $41.0B | −$76.7M | 0 | 5.3% | 105% | +34.2% | 1 | – | |
| 11 | $83.63 | −0.82% | $34.3B | $0 | 0 | 0.30% | 80.3% | +20.8% | 8 | 2.3% | |
| 12 | $54.73 | −7.4% | $32.7B | −$17.0M | 0 | 16.3% | 53.9% | +28.1% | – | 7.4% | |
| 13 | $54.87 | −9.7% | $30.3B | −$868M | 0 | 41.9% | 72.3% | +23.7% | 3 | 10.9% | |
| 14 | $36.91 | −1.6% | $26.7B | −$44.9M | 0 | 14.3% | 78.1% | +12.2% | 1 | 5.4% | |
| 15 | $124.15 | −7.1% | $25.7B | −$10.9M | 0 | 24.6% | 62.9% | +23.2% | – | 6.3% | |
| 16 | $73.47 | −1.8% | $24.8B | −$18.7M | 0 | 1.4% | 77.1% | +11.1% | 2 | 5.3% | |
| 17 | $91.73 | −29.2% | $17.6B | −$35.5M | 0 | 96.6% | 65.8% | +12.2% | 5 | 11.5% | |
| 18 | $343.12 | −1.6% | $16.4B | $0 | 0 | 1.6% | 101% | +11.2% | 3 | 5.2% | |
| 19 | $94.39 | −4.5% | $11.6B | −$69.0M | 0 | 11.0% | 93.1% | +27.0% | 1 | 5.3% | |
| 20 | $21.65 | −3.0% | $11.5B | −$17.2M | 0 | 45.7% | 69.0% | +18.2% | – | 7.7% | |
| 21 | $11.04 | −3.0% | $11.5B | – | – | 41.4% | 85.8% | +10.3% | 1 | 11.3% | |
| 22 | $57.50 | +1.2% | $11.2B | – | – | 88.4% | 37.3% | +11.3% | 2 | – | |
| 23 | $83.53 | −0.64% | $10.8B | −$33.0M | 1 | 59.2% | 25.9% | +11.4% | – | 3.1% | |
| 24 | $77.02 | −1.2% | $10.6B | −$21.4M | 0 | 15.4% | 103% | +21.6% | 1 | 8.6% | |
| 25 | $24.30 | −7.2% | $9.9B | −$317K | 0 | 26.2% | 47.0% | +15.4% | – | 4.7% | |
| 26 | $332.29 | +2.4% | $9.8B | −$26.2M | 0 | 17.2% | 102% | +14.7% | – | 11.7% | |
| 27 | $110.19 | −1.1% | $9.6B | – | – | 0.93% | 98.4% | +10.8% | – | 5.4% | |
| 28 | $56.15 | −4.8% | $9.4B | −$1.6M | 0 | 0.38% | 104% | +13.4% | – | 4.3% | |
| 29 | $30.37 | −1.4% | $9.4B | −$26.8M | 0 | 20.9% | 64.7% | +21.1% | – | 5.3% | |
| 30 | $61.18 | +5.3% | $9.4B | −$275K | 0 | 16.1% | 72.6% | +17.3% | – | 20.0% | |
| 31 | $35.92 | +0.17% | $8.6B | $0 | 0 | 66.3% | 14.5% | +41.2% | – | 3.8% | |
| 32 | syreSpyre Therapeutics | $96.56 | −2.4% | $8.5B | −$10.6M | 0 | 20.4% | 109% | +33.8% | – | 14.6% |
| 33 | $53.76 | −0.83% | $8.3B | −$1.5M | 0 | 98.6% | 52.9% | +10.0% | – | 3.2% | |
| 34 | $28.52 | 0.00% | $8.3B | $0 | 0 | 73.6% | 28.2% | +45.5% | 1 | 3.8% | |
| 35 | $76.29 | −1.9% | $8.3B | $0 | 0 | 5.2% | 90.0% | +10.2% | 1 | 5.7% | |
| 36 | $41.00 | −1.3% | $7.9B | $0 | 0 | 1.0% | 99.4% | +10.7% | – | 3.8% | |
| 37 | $25.81 | −9.0% | $7.9B | $0 | 0 | – | 55.9% | +72.8% | 1 | 4.7% | |
| 38 | $23.38 | −1.7% | $7.7B | −$4.7M | 0 | – | 109% | +11.0% | – | 8.5% | |
| 39 | $110.90 | −3.4% | $7.7B | −$1.7M | 0 | 2.9% | 94.6% | +12.9% | – | 7.1% | |
| 40 | $47.81 | −3.8% | $7.6B | −$39.8M | 0 | 78.7% | 31.3% | +10.1% | – | 2.6% | |
| 41 | $65.55 | +1.0% | $7.4B | $0 | 0 | 0.04% | 14.7% | +30.3% | 1 | 2.7% | |
| 42 | $59.40 | −10.6% | $7.3B | −$2.5M | 0 | 8.5% | 78.5% | +27.9% | 4 | 15.4% | |
| 43 | $18.34 | −1.1% | $7.2B | $0 | 0 | – | 13.8% | +16.0% | – | 1.3% | |
| 44 | $24.34 | +0.12% | $6.9B | −$63.8K | 0 | 0.38% | 110% | +12.3% | – | 11.5% | |
| 45 | $165.13 | −3.8% | $6.8B | −$4.4M | 0 | 1.5% | 109% | +12.3% | – | 8.3% | |
| 46 | $26.10 | −2.0% | $6.8B | −$13.9M | 0 | 55.0% | 64.6% | +40.5% | – | 4.5% | |
| 47 | $322.75 | +1.7% | $6.4B | −$14.5M | 0 | 2.6% | 114% | +15.6% | – | – | |
| 48 | $96.87 | +0.23% | $6.4B | −$17.9M | 0 | 47.7% | 112% | +39.1% | 1 | 11.7% | |
| 49 | $51.31 | +3.3% | $6.3B | $0 | 0 | 1.7% | 104% | +10.7% | – | 15.1% | |
| 50 | $16.00 | −11.7% | $6.3B | +$44.8K | 2 | 51.5% | 37.2% | +19.6% | – | 8.3% |